50 years after the birth of special education, some fear for its future under Trump

The Trump administration has signed a significant agreement with Kenya, marking the first of many anticipated 'America First' global health deals aimed at combating infectious diseases in countries aligned with U.S. foreign policy goals. This initiative underscores a strategic shift in U.S. health diplomacy.

The Trump administration's efforts to promote biomedical innovation and enhance the U.S. competitive edge against China are facing significant challenges, including unexpected delays, internal conflicts, and a staffing crisis within the FDA. These issues are causing growing unease among investors who are concerned about the agency's ability to facilitate timely advancements in healthcare.

Twelve former commissioners of the F.D.A. expressed serious concerns regarding a leaked memo from the Trump administration's chief scientific officer, which suggests potential changes to vaccine policy. The memo has raised alarms about the safety and efficacy of Covid-19 vaccines, which have been widely accepted by the scientific community as safe. Health Secretary Robert F. Kennedy Jr. has been vocal in his criticism of these vaccines, labeling them as dangerous despite the prevailing scientific consensus.

The Vaccine Committee is considering significant changes to the childhood vaccination schedule, including potential delays in hepatitis B shots and discussions on revising the use of other vaccines. Comments from President Trump and Health Secretary Robert F. Kennedy Jr. indicate a shift towards separating combination vaccines into individual shots.